Evidence map›Paper›PMID 27936396›Full record

ArticleBlood cells, molecules & diseases2017

GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.

James C Barton, Wen-Pin Chen, Mary J Emond, Pradyumna D Phatak, V Nathan Subramaniam, Paul C Adams, Lyle C Gurrin, Gregory J Anderson, Grant A Ramm, Lawrie W Powell and 5 more

Open access · greenAbstract read
In one paragraph

Article in Blood cells, molecules & diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Revisiting hemochromatosis: geneticAnnals of translational medicine · 2021
    Review
  3. International journal of molecular sciences · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Inherited iron overload disorders.Translational gastroenterology and hepatology · 2020
    Review
  8. Haemochromatosis.Nature reviews. Disease primers · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 3 countries.

James C BartonSouthern Iron Disorders Center, Birmingham, AL, 35209, USA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: ironmd@isp.com.
Wen-Pin ChenChao Family Comprehensive Cancer Center, Irvine, CA 92697, USA.
Mary J EmondDepartment of Biostatistics, University of Washington, Seattle, WA 98195, USA.
Pradyumna D PhatakRochester General Hospital, Rochester, NY 14621, USA.
V Nathan SubramaniamQIMR Berghofer Medical Research Institute, Brisbane City, QLD 4006, Australia; Faculty of Medicine and Biomedical Sciences, The University of Queensland, Herston, QLD, 4006, Australia.
Paul C AdamsDepartment of Medicine, London Health Sciences Centre, London, Ontario, N6A 5W9, Canada.
Lyle C GurrinCentre for MEGA Epidemiology, The University of Melbourne, Victoria 3010, Australia.
Gregory J AndersonQIMR Berghofer Medical Research Institute, Brisbane City, QLD 4006, Australia; School of Medicine and School of Chemistry and Molecular Bioscience, University of Queensland, Brisbane, St. Lucia, QLD 4072, Australia.
Grant A RammQIMR Berghofer Medical Research Institute, Brisbane City, QLD 4006, Australia; Faculty of Medicine and Biomedical Sciences, The University of Queensland, Herston, QLD, 4006, Australia.
Lawrie W PowellQIMR Berghofer Medical Research Institute, Brisbane City, QLD 4006, Australia; Faculty of Medicine and Biomedical Sciences, The University of Queensland, Herston, QLD, 4006, Australia; Royal Brisbane & Women's Hospital, Herston, QLD, 4029, Australia.
Katrina J AllenMurdoch Childrens Research Institute, Parkville, Victoria 3052, Australia.
John D PhillipsDepartments of Medicine and Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Charles J ParkerDivision of Hematology and Hematologic Malignancies, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Gordon D McLarenDepartment of Veterans Affairs Long Beach Healthcare System, Long Beach, CA 90822, USA; Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, CA 92868, USA.
Christine E McLarenDepartment of Epidemiology, University of California, Irvine, CA 92697, USA.
QIMR Berghofer Medical Research Institute · AUUniversity of Queensland · AUUniversity of Utah · USCommunity Cancer Center · USLondon Health Sciences Centre · CAMurdoch Children's Research Institute · AURochester General Hospital · USUniversity of Alabama at Birmingham · USUniversity of California, Irvine · USUniversity of Melbourne · AUUniversity of Washington · USVA Long Beach Healthcare System · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Proteomics CoreU54DK110858 · NIDDK · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anna E Beaudin, JAMES Eric COX · 2016 to 2026
$8.6M
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y HomozygotesR24DK099846 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI ADAMS, PAUL CLIFFORD, BARTON, JAMES C · 2014 to 2016
$2.0M
Regulation of Iron HomeostasisR01DK090257 · NIDDK · UNIVERSITY OF UTAH · PI PHILLIPS, JOHN DEARBORN · 2010 to 2014
$1.8M
Genetic Modifiers of Iron Status in Hemochromatosis HFE C282Y HomozygotesR24DK093433 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI MCLAREN, CHRISTINE E., MCLAREN, GORDON D · 2011 to 2011
$376k
NCI NIH HHS P30 CA062203NIDDK NIH HHS R01 DK090257NIDDK NIH HHS R24 DK093433NIDDK NIH HHS R24 DK099846NIDDK NIH HHS U54 DK110858
6 · The paper itself

Abstract

backgroundGNPAT p.D519G positivity is significantly increased in HFE p.C282Y homozygotes with markedly increased iron stores. We sought to determine associations of p.D519G and iron-related variables with iron stores in p.C282Y homozygotes.

methodsWe defined markedly increased iron stores as serum ferritin >2247pmol/L (>1000μg/L) and either hepatic iron >236μmol/g dry weight or iron >10g by induction phlebotomy (men and women). We defined normal or mildly elevated iron stores as serum ferritin <674.1pmol/L (<300μg/L) or either age≥40y with iron ≤2.5g iron by induction phlebotomy or age≥50y with ≤3.0g iron by induction phlebotomy (men only). We compared participant subgroups using univariate methods. Using multivariable logistic regression, we evaluated associations of markedly increased iron stores with these variables: age; iron supplement use (dichotomous); whole blood units donated; erythrocyte units received as transfusion; daily alcohol consumption, g; and p.D519G positivity (heterozygosity or homozygosity).

resultsThe mean age of 56 participants (94.6% men) was 55±10 (SD) y; 41 had markedly increased iron stores. Prevalences of swollen/tender 2nd/3rd metacarpophalangeal joints and elevated aspartate or alanine aminotransferase were significantly greater in participants with markedly increased iron stores. Only participants with markedly increased iron stores had cirrhosis. In multivariable analyses, p.D519G positivity was the only exposure variable significantly associated with markedly increased iron stores (odds ratio 9.9, 95% CI [1.6, 60.3], p=0.0126).

conclusionsGNPAT p.D519G is strongly associated with markedly increased iron stores in p.C282Y homozygotes after correction for age, iron-related variables, and alcohol consumption.

Indexed as

Mutation, MissenseAcyltransferasesAdultAgedAge FactorsAlcohol DrinkingFemaleHemochromatosis ProteinHomozygoteHumansIronMaleMiddle AgedAcyltransferasesglycerone-phosphate O-acyltransferaseHemochromatosis ProteinIronHemochromatosisIron overloadrs11558492rs1800562

Identifiers

PMID27936396
PMCPMC5629344
OpenAlexW2551581358

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.